| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.004 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.006 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |